CNIPA.AI

Company patentsCompare

HEAD TO HEAD

Eli LillyMicrosoftTencent

Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.

Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds

This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.

Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.

Eli Lilly: Applicant names included in these statistics — ELI LILLY AND CO · ELI LILLY AND COMPANY USA · LILLY CO ELIReviewed names not covered — ELI LILLY AND COMPANY

Microsoft: Applicant names included in these statistics — MICROSOFT TECHNOLOGY LICENSING LLCReviewed names not covered — MICROSOFT TECHNOLOGY LICENSING, LLC · MICROSOFT TECHNOLOGY LICENSING, LLC.

Tencent: Applicant names included in these statistics — TENCENT AMERICA LLC · TENCENT TECH SHENZHEN CO LTDReviewed names not covered — TENCENT TECHNOLOGY (SHENZHEN) CO., LTD. · TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED · 腾讯科技(深圳)有限公司 · 腾讯美国有限责任公司

Eli Lilly

Publications
1,602
Invention share
45%
Concentration
0.73
Green technology
—

Microsoft

Publications
7,140
Invention share
97%
Concentration
0.59
Green technology
—

Tencent

Publications
9,476
Invention share
99%
Concentration
0.40
Green technology
—
0.01

Eli Lilly × Microsoft

0.01

Eli Lilly × Tencent

0.95

Microsoft × Tencent

Cosine similarity of application counts across 35 fields. 1 is identical, 0 is no overlap.

01Technology field mirror

The 12 fields with the largest combined share. Share shows structure; count shows scale.

Technology field mirror
Technology fieldEli Lilly / Microsoft / Tencent
Computer technology
0.6%
72.5%
53.4%
Pharmaceuticals
68.5%
0%
0.1%
Digital communication
0.1%
22.4%
19.4%
Biotechnology
39.9%
0.4%
0.1%
Audio-visual technology
0.1%
10.5%
23.4%
Organic fine chemistry
25.8%
0.2%
0%
Medical technology
17.6%
0.7%
0.4%
Furniture, games
0%
1%
12.3%
IT methods for management
0.2%
4.2%
8.7%
Measurement
1%
2.1%
1.3%
Telecommunications
0%
3.3%
1%
Optics
0%
3.8%
0.5%

Inspect one technology field

Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.

Tencent

Collected applications
2,137
Share of collected applications with IPC
23.4%

Coverage is incomplete; counts and shares describe only the collected subset.

View Tencent publications in this field

One application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.

02Same problem: shared IPC subclasses

The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.

G06FData processing
Eli Lilly2
Microsoft3,890
Tencent3,074
G06NComputing models, AI
Eli Lilly3
Microsoft1,064
Tencent1,015
G06TImage processing
Eli Lilly5
Microsoft479
Tencent1,220
G06QBusiness data processing
Eli Lilly3
Microsoft290
Tencent795
G06VImage and video recognition
Eli Lilly2
Microsoft295
Tencent742
H04WWireless networks
Eli Lilly2
Microsoft196
Tencent236
C12NMicroorganisms, enzymes
Eli Lilly153
Microsoft11
Tencent6
G16H
Eli Lilly36
Microsoft30
Tencent21
A61BMedical diagnosis
Eli Lilly36
Microsoft20
Tencent21
G01NAnalysing materials
Eli Lilly32
Microsoft12
Tencent9

03Where each one leans

Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.

Eli Lilly

  • A61K
    Eli Lilly
    926
    Microsoft
    —
    Tencent
    10
  • A61P
    Eli Lilly
    766
    Microsoft
    —
    Tencent
    11
  • C07K
    Eli Lilly
    454
    Microsoft
    —
    Tencent
    6
  • C07DHeterocyclic compounds
    Eli Lilly
    300
    Microsoft
    —
    Tencent
    3
  • A61M
    Eli Lilly
    196
    Microsoft
    —
    Tencent
    —
  • C12NMicroorganisms, enzymes
    Eli Lilly
    153
    Microsoft
    11
    Tencent
    6

Microsoft

  • G06FData processing
    Eli Lilly
    2
    Microsoft
    3,890
    Tencent
    3,074
  • H04LDigital transmission
    Eli Lilly
    —
    Microsoft
    1,379
    Tencent
    1,218
  • G06NComputing models, AI
    Eli Lilly
    3
    Microsoft
    1,064
    Tencent
    1,015
  • G02BOptical elements
    Eli Lilly
    —
    Microsoft
    236
    Tencent
    32
  • H05KPrinted circuits, assemblies
    Eli Lilly
    —
    Microsoft
    164
    Tencent
    14
  • H04BTransmission
    Eli Lilly
    —
    Microsoft
    108
    Tencent
    29

Tencent

  • H04NPictorial communication, video
    Eli Lilly
    —
    Microsoft
    482
    Tencent
    2,479
  • A63F
    Eli Lilly
    —
    Microsoft
    69
    Tencent
    1,123
  • G06TImage processing
    Eli Lilly
    5
    Microsoft
    479
    Tencent
    1,220
  • G06QBusiness data processing
    Eli Lilly
    3
    Microsoft
    290
    Tencent
    795
  • G06VImage and video recognition
    Eli Lilly
    2
    Microsoft
    295
    Tencent
    742
  • B25JManipulators, robots
    Eli Lilly
    —
    Microsoft
    —
    Tencent
    77

04Publication rhythm

Eli LillyMicrosoftTencentPublications per period
Publications per period
PeriodEli LillyMicrosoftTencent
2025-01≥118 (partial coverage)≥539 (partial coverage)≥697 (partial coverage)
2025-02≥121 (partial coverage)≥503 (partial coverage)≥725 (partial coverage)
2025-03≥158 (partial coverage)≥603 (partial coverage)≥558 (partial coverage)
2025-04≥110 (partial coverage)≥647 (partial coverage)≥573 (partial coverage)
2025-05≥134 (partial coverage)≥566 (partial coverage)≥924 (partial coverage)
2025-06≥140 (partial coverage)≥487 (partial coverage)≥601 (partial coverage)
2025-07≥138 (partial coverage)≥686 (partial coverage)≥1,207 (partial coverage)
2025-08≥134 (partial coverage)≥563 (partial coverage)≥809 (partial coverage)
2025-09≥132 (partial coverage)≥587 (partial coverage)≥875 (partial coverage)
2025-10≥155 (partial coverage)≥689 (partial coverage)≥937 (partial coverage)
2025-11≥140 (partial coverage)≥582 (partial coverage)≥761 (partial coverage)
2025-12≥122 (partial coverage)≥688 (partial coverage)≥809 (partial coverage)

Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.

Publication timing follows examination and publication cycles, not R&D intensity.

What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.

What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.

Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.